Radiolabeled biologics whether amino acids, cells, antibodies, proteins, viruses or synthetic ligands have potential for functional imaging and therapy. To ...

Researchers at Washington University School of Medicine in St. Louis have conducted a longitudinal study on an individual ...

The company’s RAD 101 imaging molecule identified brain tumours in all 12 treatment-naïve patients in a proof-of-concept ...

Successful detection of brain metastases using RAD 101 (18F-Pivalate) in a novel multiparametric imaging methodology (PET-mpMRI) study across 22 ...

Radiopharm Theranostic (RADX)s announced the publication of a novel imaging approach demonstrating proof-of-concept for the use of RAD 101 for ...

Positron Co. (OTCMKTS:POSC – Get Free Report) shares fell 6.2% during mid-day trading on Friday . The company traded as low as $1.78 and last traded at $1.81. 34,998 shares traded hands during trading ...

Lantheus, a Massachusetts-based developer of radiopharmaceuticals, has agreed to acquire the radiopharma contract development and manufacturing organization (CDMO) Evergreen Theragnostics. Lantheus ...

The School of Medicine is a major international centre for teaching and research, and committed to the pursuit of improved human health. We combine progressive healthcare education and patient care ...

Researchers from Astrazeneca plc and Karolinska Institutet have described the positron emission tomography (PET) evaluation of [11C]AZD-2423, a chemokine receptor type 2 (CCR2) radioligand in ...

With the aim to add a “revenue generating CDMO arm,” Lantheus Holdings has bought New Jersey-based radiopharmaceutical ...

The study indicated delayed REM sleep is a novel marker or risk factor for AD/ADRD pathogenesis. Throughout the study, Prolonged REML (rapid eye movement latency) was associated with higher amyloid ...

The Co-IMPACT consortium addresses knowledge gaps in prostate-specific membrane antigen positron emission tomography-guided radiotherapy for prostate cancer by establishing a global database (46 ...